Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ROSEN, A LEADING LAW FIRM, Encourages Banco Santander, S.A. Investors to Inquire About Securities Class Action Investigation – SAN
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages iRobot Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IRBT
-
IB Acquisition Corp. Announces Pricing of $100,000,000 Initial Public Offering
-
SBA Administrator Guzman Signs Strategic Alliance Memorandum with National Association of Workforce Boards to Strengthen Workforce Development
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMLX
-
Dada Announces Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results
-
Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results
-
Australian Fintech Stables Launches International Remittances Between Australia and The Philippines
-
Readout of SBA Administrator Isabel Casillas Guzman’s Convening of Child Care Conference
-
CaymanStory.com Personal Branding Master Class for Cayman Islands Entrepreneurs Second Batch 2024
-
CORRECTION: Dividend Payment Date Adjustment Due to Canadian Statutory Holiday
-
ThreeD Capital Inc. Announces New YouTube Channel (AMENDED)
-
SaverOne Reports Full Year 2023 Results with 128% Year-over-Year Revenue Growth
-
Lumine Group Inc. Completes Mandatory Conversion of its Preferred Shares and Special Shares
-
Waldencast Regains Compliance with Nasdaq Filing Requirements
-
Forza Lithium Announces the Closing of Planet Green Metals Inc. Merger
-
Precipio Announces Year end 2023 Shareholder Update Call
-
Orion Group Holdings, Inc. Announces Retirement of Board Member
-
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
-
Ibogaine By David Dardashti Explains the Legal Status of Ibogaine
-
AppTech Payments Corp. Announces Proposed Underwritten Public Offering of Common Stock
-
INNOVATE Corp. Announces Extension of Rights Offering Subscription Period
-
Four PCA Member Companies Awarded More Than $1 Billion from U.S. DOE
-
Goodness Growth Holdings Reschedules Fourth Quarter and Full Year 2023 Results Call to April 1, 2024
-
Freddie Mac Issues Monthly Volume Summary for February 2024
-
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
-
Coherent to Present a Broad Portfolio of New Products and Technology Innovations at OFC 2024
-
Agile Therapeutics Announces Delisting from Nasdaq
-
Zevra Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
-
TIAN RUIXIANG Holdings Ltd Receives Notification of Non-compliance from Nasdaq Relating to Late Filing of Annual Report on Form 20-F
-
Nokia Corporation: Repurchase of own shares on 25.03.2024
-
NOTICE TO DISREGARD -- Atomic Data
-
Enstar Subsidiary Assigned ‘A’ Financial Strength Rating by S&P Global
-
Enstar Subsidiary Assigned ‘A’ Financial Strength Rating by S&P Global
-
MRC Global Announces First Quarter 2024 Earnings Release, Conference Call and Webcast Schedule
-
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules First Quarter 2024 Conference Call for May 1, 2024
-
ARMOUR Residential REIT, Inc. Announces Guidance for April 2024 Dividend Rate Per Common Share
-
Diamondback Energy, Inc. Schedules First Quarter 2024 Conference Call for May 1, 2024
-
Glorious Finale: Rugby Sevens Illuminates Hong Kong Stadium Embarking on an Exciting Chapter at Kai Tak Sports Park
-
Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
-
ConnectWise Earns Premier 5-Star Rating in 2024 CRN® Partner Program Guide
-
Sonoco Implementing Price Increase for Uncoated Recycled Paperboard in Europe
-
TMC Announces Fourth Quarter and Full Year 2023 Results
-
Nilam Resources Enters Letters of Intent to Acquire 24,800 Bitcoin
-
NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference
-
Financial Institutions, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call
-
Tenable Earns Premier 5-Star Rating in 2024 CRN Partner Program Guide
-
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
-
Fossil Group Announces Appointment of Eugene Davis and Pamela Corrie to Board of Directors
-
Shapeways Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

